Neos Therapeutics' (NEOS) share price has crashed as a result of the pandemic, but contrary to most other pharma companies, its share price hasn't recovered:
The main reasons for the share price collapse are the pandemic and unusually low wholesale inventory levels, producing declines in subscriptions. However, both of these are temporary.
So when these subside (needless to say the pandemic is still raging), there will be room for shares to recover, especially as the company is cutting a significant amount of cost and its RxConnect platform is still growing.
But the company